As of 2025, lawsuits are now underway against Pfizer, the manufacturer of Depo-Provera, filed by women who were diagnosed with meningioma after using the birth control shot. These cases allege that ...

WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

Women in the UK are calling for a review of the Depo-Provera contraceptive injection after developing brain tumours they ...

The FDA has approved a critical label change for Pfizer's widely used Depo-Provera birth control injection, adding a warning about the risk of meningioma—a typically non-cancerous but potentially ...

Meningioma brain tumors are often described as slow-growing and benign. But for many patients, the effects are anything but minor. These tumors can press on critical areas of the brain, leading to ...

This week, the FDA approved a label change on Depo Provera, requiring its maker, Pfizer, to warn women about links between use of the birth control injection and brain tumors known as meningiomas.

Pfizer’s battle over the safety label for its birth control injection has finally come to a close. The pharma giant announced that the Food and Drug Administration approved its new safety warning ...

WASHINGTON (7News) — Millions of women in the United States trust the safety of their birth control, never imagining it could lead to severe health conditions like a brain tumor. Yet, cases across the ...

Thousands of women have filed Depo-Provera lawsuits, saying they developed brain tumors due to their use of the birth control shot. CHESTNUT HILL, MA / ACCESS Newswire / May 20, 2026 / One of the ...

The FDA approved a label change for Pfizer’s birth control injection Depo-Provera on Dec. 13, adding a warning about the risk of meningioma — a brain tumor — to two versions of the drug. The update ...